FAM10A4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.234640E-01
Normal-vs-Stage2
8.522800E-01
Normal-vs-Stage3
2.099200E-01
Normal-vs-Stage4
4.063400E-01
Stage1-vs-Stage2
2.226000E-01
Stage1-vs-Stage3
6.821600E-03
Stage1-vs-Stage4
9.517600E-01
Stage2-vs-Stage3
2.450000E-01
Stage2-vs-Stage4
2.933600E-01
Stage3-vs-Stage4
1.120780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.983800E-01
Normal-vs-AfricanAmerican
3.100200E-01
Normal-vs-Asian
5.483000E-01
Caucasian-vs-AfricanAmerican
3.282600E-01
Caucasian-vs-Asian
1.102580E-01
AfricanAmerican-vs-Asian
6.328200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.413600E-01
Normal-vs-Female
7.580400E-01
Male-vs-Female
7.937200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.252800E-01
Normal-vs-Age(41-60Yrs)
3.974800E-01
Normal-vs-Age(61-80Yrs)
9.943600E-01
Normal-vs-Age(81-100Yrs)
7.921200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.002600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.686400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.044400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.939800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.770300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.124400E-01
Normal-vs-Daily Drinker
4.620000E-01
Normal-vs-Weekly Drinker
8.982000E-01
Normal-vs-Occasional Drinker
5.391000E-01
Normal-vs-Social Drinker
5.458800E-01
Non Drinker-vs-Daily Drinker
3.568000E-01
Non Drinker-vs-Weekly Drinker
2.711600E-01
Non Drinker-vs-Occasional Drinker
2.176200E-02
Non Drinker-vs-Social Drinker
6.999700E-02
Daily Drinker-vs-Weekly Drinker
1.364990E-01
Daily Drinker-vs-Occasional Drinker
1.394110E-02
Daily Drinker-vs-Social Drinker
1.969910E-02
Weekly Drinker-vs-Occasional Drinker
3.978800E-01
Weekly Drinker-vs-Social Drinker
3.598400E-01
Occasional Drinker-vs-Social Drinker
8.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.725600E-01
Normal-vs-Grade 2
8.741800E-01
Normal-vs-Grade 3
8.628800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.868000E-01
Grade 1-vs-Grade 3
6.915600E-01
Grade 1-vs-Grade 4
7.725600E-01
Grade 2-vs-Grade 3
8.398400E-01
Grade 2-vs-Grade 4
8.741800E-01
Grade 3-vs-Grade 4
8.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.940600E-01
Normal-vs-NonDiabetic
8.490200E-01
Diabetic-vs-NonDiabetic
5.259000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.457200E-01
Normal-vs-NoPancreatitis
8.598800E-01
Pancreatitis-vs-NoPancreatitis
5.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.435000E-01
Normal-vs-N1
8.279200E-01
N0-vs-N1
5.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.807800E-01
Normal-vs-TP53-NonMutant
7.480800E-01
TP53-Mutant-vs-TP53-NonMutant
7.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
